Dr Astrid Glaser

Research Unit

Genome stability


Postdoctoral Research Officer

Professional Experience

2019                PhD Genetics, University of Melbourne
2018–present  Postdoctoral Research Officer, St Vincent’s Institute of Medical                                 Research
2013                Diploma in Microbiology and Genetics (equivalent to a master’s                              degree), University of Vienna


September 2016   Best Gene Therapy Paper Award from the Australasian                                              Gene and Cell Therapy Society (AGCTS)

March 2014          Melbourne International Fee Remission Scholarship (MIFRS)                                     and Melbourne International Research Scholarship (MIRS)

Research Interests

Genome editing (CRISPR/Cas9). DNA damage repair. Gene therapy.

Selected Publications

  1. Howden SE, McColl B, Glaser A, Vadolas J, Petrou S, Little MH, Elefanty AG, Stanley EG. (2016). A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells. Stem Cell Reports. 7(3):508-517.
  2. Glaser A, McColl B, Vadolas J. (2016). GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9-mediated Genome Editing. Mol Ther Nucleic Acids. 5(7):e334.
  3. Glaser A, McColl B, Vadolas J. (2015). The therapeutic potential of genome editing for β-thalassemia. F1000 Faculty Rev-1431
  4. Kalb ML, Glaser A, Stary G, Koszik F, Stingl G. (2012). TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity. J Immunol. 188(4):1583-91